Fortaleza Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Fortaleza Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$87K	Sell	1,130 -510	-31%	-$32.9K	0.71%	79
2018 Q1	$84K	Hold	1,640	–	–	0.51%	85
2017 Q4	$76K	Hold	1,640	–	–	0.48%	85
2017 Q3	$87K	Hold	1,640	–	–	0.16%	143
2017 Q2	$102K	Hold	1,640	–	–	0.19%	139
2017 Q1	$111K	Buy	1,640 +980	+148%	+$74.7K	0.22%	126
2016 Q4	$46K	Hold	660	–	–	0.1%	146
2016 Q3	$46.8K	Hold	660	–	–	0.07%	144
2016 Q2	$32K	Sell	660 -340	-34%	-$22K	0.03%	138
2016 Q1	$63.3K	Hold	1,000	–	–	0.04%	133
2015 Q4	$112K	Sell	1,000 -20	-2%	-$2K	0.07%	125
2015 Q3	$98K	Buy	+1,020	New	+$117K	0.07%	131

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fortaleza Asset Management's RARE Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 31% in Q2 2018, selling an estimated $32.9K and leaving 1,130 shares worth $87K. The position accounts for 0.71% of the portfolio, ranked #79.

Fortaleza Asset Management first reported a position in RARE in Q3 2015 and has held it in 12 quarters since. The position peaked at $112K in Q4 2015. 158 funds tracked by Wall St. Rank hold RARE as of Q2 2018.

Fortaleza Asset Management held 1,130 shares of Ultragenyx Pharmaceutical worth $87K as of Q2 2018.
Fortaleza Asset Management sold 510 Ultragenyx Pharmaceutical shares in Q2 2018, an estimated $32.9K.
Ultragenyx Pharmaceutical made up 0.71% of Fortaleza Asset Management's portfolio in Q2 2018, its #79 holding.
Fortaleza Asset Management first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and has held it in 12 quarters since.
Fortaleza Asset Management's Ultragenyx Pharmaceutical position peaked at $112K in Q4 2015.
158 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.